As part of the 2015-16 Commonwealth Budget the Australian Government accepted the Medical Services Advisory Committee’s (MSAC) recommendation to change the National Cervical Screening Program (NCSP) to replace the two-yearly Pap test with five-yearly primary HPV tests. This change is scheduled to take effect from 1 May 2017.
The changes to the National Cervical Screening Program are expected to have an impact on the Australian cytology workforce. The NCSP Renewal has identified the need to support this workforce change and the Royal College of Pathologists of Australasia (RCPA) is leading a project to assist with this, funded by the NCSP Renewal.
The Steering Committee for this project is:
Dr David Papadimos (Chair)
Dr Lyndal Anderson (NCOPP)
Dr Chris Carter (ASC)
Dr Annabelle Farnsworth (PA)
Dr Elizabeth Salisbury (RCPA)
Project Officer: Gillian Phillips
This website provides information to support cytologists through the transition to the new screening pathway.
Contact RCPA - questions and feedback are welcomed
Impact on current workforce and career transition information.
standards and quality monitoring.
Common LBC presentations